Study of estimation of serum LDH and uric acid in preeclampsia and it’s clinical correlation


  • Geetha Shivamurthy Department of Obstetrics and Gynaecology, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India
  • Nandini Smanjunath Department of Obstetrics and Gynaecology, Bangalore Medical College and Research Institute, Bangalore, Karnataka, India



Preeclampsia, Serum LDH, Uric acid


Background: Preeclampsia occurs in 2-8% of pregnancies and a leading cause of maternal and perinatal mortality and morbidity. The objective of this study was to compare serum lactate dehydrogenase (LDH) and uric acid levels in normotensive pregnant women and in women with preeclampsia and to correlate the maternal and perinatal outcomes and severity of the disease with serum LDH and uric acid levels

Methods: A prospective case control study conducted during the period of 18 months involving 100 normotensive pregnant women and an equal no. of patients with preeclampsia admitted under OBG department, Vani Vilas Hospital and Bowring and Lady Curzon hospital, which are affiliated to BMCRI, Bangalore. They were followed up till delivery and early post-partum period. Serum LDH and uric acid levels were sent and maternal and foetal outcomes studied.

Results: There was statistically significant increase in levels of serum LDH and uric acid among cases compared to control group. Higher levels were also associated with significant maternal and foetal complications.

Conclusions: We conclude from this study that the serum LDH and Uric acid are the inexpensive and reliable markers to predict severity and maternal and foetal outcomes in patients with preeclampsia.


Von Dadleszen, Mageela P, Taylor, Muir JC, Stewart SD. Maternal hypertension and neonatal outcome among small for gestational age infants. Obstet Gynecol. 2005;106:335-9.

Mutlu TU, Ademoglu E. Imbalance between lipid peroxidation, antioxidant status in preeclampsia. Gynecol Obstet Invest. 1998;46:37-40.

Maternal mortality in 2005: estimates developed by WHO, UNICEF, VNIFPA and the World Bank, Geneva. World Health Organization, 2007. Accessed on 25 July 2020.

Kathleen A, Pennington, Schlitt JM, Jackson DL, Schulz LC, Schust DJ. Preeclampsia: Multiple approaches for a multifactorial disease, disease models and mechanisms. 2012;5:9-18.

Powe C, Levine R, Karumanchi S. Preeclampsia, a disease of the maternal endothelium:the role of angiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856-69.

Vasudevan D, Sreekumari S, Vaidyanathan K. Kidney fuction tests. In: Textbook of biochemistry, 6th edition. New Delhi, Jaypee Brothers, 2011;314-28.

Cunningham GF, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL et al (editors). Wlliams Obstetrics. 24rd Edition. The McGraw Hill Education. 2014:1512.

Umasatyasri Y, Vani I, Shamita P. Role of LDH in preeclampsia-eclampsia as a prognostic marker: An observational study. IAIM. 2015;2(9):88-93.

Yadav BS, Jain SK, Toppo NA, Deharia C. A case control study on s.uric acid and s. creatinine levels in pre-eclampsia patients of a tertiary care hospital in Jabalpur district of Central India. Int J Res Med Sci. 2018;6:1519-24.

Sonagra DA, Dattatreya K, Murthy DSJ. Serum LDH, ALP and Uric Acid in Hypertensive Disorders of Pregnancy. International Journal of Pharmacy and Biological Sciences. 2012;2(3):201-9.

Gandhi M, Chavda R, Saini HB. Comparative study of serum LDH and Uric acid in hypertensive versus normotensive pregnant women. International Journal of Biomedical Research. 2015;6(01):25-8.

Qublan H, Ammarin V, Bataineh O, Al-Shraideh Z, Tahat Y, Awamleh I et al. Lactic dehydrogenase as biochemical marker of adverse pregnancy outcome in severe preeclampsia. Med Sci Monit. 2005;11(8):CR393-7.






Original Research Articles